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The infection with the new severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), which is responsible for
causing the coronavirus disease 2019 (COVID-19), became a
devastating threat to the health of the world population and
was declared a global pandemic by the World Health Orga-
nization (WHO) onMarch 11, 2020. Beginning in China at the
end of 2019, it quickly spread to several countries, and the
first case was officially diagnosed in Brazil on February 26,
2020. Since then, despite initial measures to slow the virus’
spread, we are alarmed by the exponential growth in the
number of cases. At the time of writing this text, Brazil
exceeds 800,000 cases and 40,000 deaths, second only to the
United States in those numbers. However, the well-known
underreportingof cases and deaths in the country, associated
with the incomprehensible decision to suspend access to the
Epidemiological Surveillance Information System - Influenza
(SIVEP-Gripe, in the Portuguese acronym) database for
recalculating the number of deaths makes it difficult to
keep these numbers up to date.
The real impact of COVID-19 on pregnancy, childbirth and
the puerperium period, and if the pregnancy-puerperal state
changes the natural history of COVID-19 are controversial
issues that remain to be elucidated. Initial studies in the
obstetric population were not suggestive of a greater sus-
ceptibility of pregnant women to COVID-19 complica-
tions.1,2 However, subsequent publications reported cases
of pregnant womenwith severe disease andmaternal deaths
from COVID-19.3–8 A Swedish study showed a higher risk of
pregnant women needing admission to the intensive care
unit compared with non-pregnant women.7 To date, reports
of maternal death have been published in Iran and Mexico
(seven cases each), in the United Kingdom (five deaths) and
in the United States (one case).4–6,8
These data raise concerns about the impact of COVID-19
on maternal mortality in Brazil. In April 2020, the Brazilian
Ministry of Health included all pregnant and puerperal
women and patients with gestational or fetal loss up to
day 15 in the risk group for COVID-19. However, until the
end of May there was no official release of aggregated death
data during pregnancy and postpartum. Amorim et al
(2020),9 using official and media data, have preliminarily
reported 5 cases of maternal death in the country until
April 10, 2020. Finally, at the end of May, the Ministry of
Health10 reported the occurrence of 36 cases of maternal
death from COVID-19 and 252 cases of severe acute respira-
tory syndrome (SARS) occurring up to epidemiological
week 21 (May 17–23, 2020).10
The identification of these 36 deaths already places Brazil
in the leadership of maternal deaths due to COVID-19 in the
world, even when adding all maternal deaths published in
the literature so far. What would justify somany deaths from
COVID-19 in our country? Is it possible that the population of
pregnant women has very different characteristics from
pregnant women in other countries, and that the presence
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of comorbidities, especially preeclampsia and obesity, which
are very common inflammatory conditions in our population
and risk factors for complications due to COVID-19, can
explain these findings?11–13 Hypertension is the leading
cause of maternal death and maternal near-miss in Brazil,
and there is evidence of a similar picture of preeclampsia
observed in women with severe COVID.14,15 Data from the
Ministry of Health show a higher incidence of hypertension
among pregnantwomen andwomenwhohave recently died,
compared with those who have had SARS and recovered
(13.9% versus 3.9%).10 Thus, when hypertension and COVID-
19 infection occur simultaneously in pregnancy, the inflam-
matory response may contribute to a worse maternal prog-
nosis. Obesity (11.1% versus 4.4%) is another condition of
high incidence among fatal cases in Brazil.10 Brazil has a high
prevalence of overweight and obese pregnant women,16 and
themetabolic syndrome is also a proinflammatory state, just
like the systemic response observed in severe cases of COVID.
In France, obesity is a risk factor for severe maternal morbid-
ity and there is no reason to suppose that such an association
is not present in Brazil.13 In addition, obesity may contribute
to maternal death because of its association with
preeclampsia.12
In Brazil, barriers to access services with specialized care
and inadequate monitoring of obstetric complications also
persist in hospitals, primary care and specialty clinics, as
evidenced in two large national studies.17,18 In addition,
there are structural deficiencies in Brazilian maternity hos-
pitals, both in physical and in human and material resources
(medicines, laboratory, etc.). In the public system, only 15% of
maternity units have an adult intensive care unit (ICU), and
the availability of places is extremely uneven across the
Brazilian territory.19 Consequently, maternal deaths in Brazil
are more related to phases II and III of delays17 and this was
possibly intensified in this pandemic period. In general, for
the better management of cases of symptomatic people
during the pandemic period, Basic Health Units have post-
poned prenatal consultations, which has increased the bar-
riers to adequate prenatal care. As a result of this approach,
pregnant women have arrived in hospitals in more serious
clinical conditions that could have been avoided with timely
and quality prenatal care.
These deficiencies in the health system, potentially aggra-
vated by the recent economic crisis and restrictions of public
investments inhealth, are put in check at thismomentbecause
all resources and attention are focused on care for the COVID-
19 pandemic. Roberton et al, in statistical modeling to assess
the indirect effects of COVID-19, estimated that maternal
mortality could increase between 8.3 and 38.6% per month
in low andmiddle income countries and that 60% of this effect
could result from the reductionof four essential interventions:
parenteral administration of uterotonics, antibiotics, anticon-
vulsants, and a clean environment for childbirth.20
At thismoment, it is difficult tomeasure the impact of the
COVID-19 pandemic on maternal mortality in Brazil. The
growing figures and media reports will certainty cause an
increase in relation to previous years. Brazil has failed to
meet the millennium goal of reducing maternal mortality by
75% from 1990 to 2015, and, since 2012, there has been no
sustained reduction in maternal mortality.21 We are still far
from the goal set by the federal government of 30 deaths per
100,000 live births by 2030 to contribute to the WHO
Sustainable Development Goals, a plan to which Brazil is a
signatory country.
In the current context of the pandemic, it is essential to
continue the usual obstetric care with prenatal care in basic
units and maternity units by facilitating pregnant women’s
access to health services, ensuring essential supplies for
hospitals with obstetric care and continuing the services of
family planning and abortion provided by law. In this partic-
ular matter, we observe with perplexity and concern the
revocation of Technical Note number 16/2020 (COSMU/
CGCIVI/DAPES/SAPES/MS), which only ensured access to
sexual and reproductive health within the pandemic context
(https://kidopilabs.com.br/planificasus/upload/covid19_a-
nexo_46.pdf). Managers should also ensure the rapid identi-
fication of pregnant and postpartumwomenwith symptoms
suggestive of COVID-19, ideally by offering universal test-
ing22,23 and making ICU beds available in a timely manner to
avoid delays in proper treatment.
Finally, it is necessary to think about the postpandemic
moment. Part of the advanced support equipment acquired
by federal entities because of COVID-19 can be reverted to
our maternity hospitals later. However, for reducing mater-
nal mortality in Brazil, it is necessary to reduce delays in
accessing the health system and receiving adequate, respect-
ful, and quality care.24 Recently, the Brazilian Federation of
Gynecology and Obstetrics Associations (FEBRASGO, in the
Portuguese acronym) Specialized National Commission on
Maternal Mortality has contributed to the debate on the
reduction of maternal mortality in Brazil by making several
proposals25 and remains at the disposal of managers to assist
in the development of proposals and implementation of
actions aimed at improving obstetric care and, consequently,
reducing maternal mortality.
The death of a woman in the pregnancy-puerperal cycle is
always a tragedy. Maternal death must be considered a pre-
ventable tragedy and every effort must be made to prevent it.
The lives of pregnant and postpartum women matter!
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